Xian Li Selected Research

Anti-Allergic Agents (Antiallergic Agents)

1/2018	Tanshinone IIA suppresses FcεRI-mediated mast cell signaling and anaphylaxis by activation of the Sirt1/LKB1/AMPK pathway.
1/2017	Sirt1 negatively regulates FcεRI-mediated mast cell activation through AMPK- and PTP1B-dependent processes.
1/2014	Curcumin inhibits the activation of immunoglobulin e-mediated mast cells and passive systemic anaphylaxis in mice by reducing serum eicosanoid and histamine levels.
12/2011	Emodin, a naturally occurring anthraquinone derivative, suppresses IgE-mediated anaphylactic reaction and mast cell activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xian Li Research Topics

Disease

91	Neoplasms (Cancer) 05/2024 - 04/2008
27	Body Weight (Weight, Body) 04/2024 - 10/2010
26	Inflammation (Inflammations) 01/2024 - 09/2010
21	Infections 12/2024 - 09/2013
15	Type 2 Diabetes Mellitus (MODY) 08/2023 - 05/2013
14	Stomach Neoplasms (Stomach Cancer) 01/2024 - 04/2013
14	Insulin Resistance 07/2022 - 02/2012
14	Obesity 01/2020 - 09/2010
12	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2017
12	Hypertension (High Blood Pressure) 09/2022 - 05/2007
10	Breast Neoplasms (Breast Cancer) 11/2023 - 01/2016
10	Anaphylaxis (Anaphylactic Shock) 09/2019 - 12/2011
10	Stroke (Strokes) 01/2019 - 12/2004
9	Lung Neoplasms (Lung Cancer) 09/2022 - 01/2014
8	Necrosis 01/2024 - 03/2012
8	Wounds and Injuries (Trauma) 01/2023 - 12/2017
7	Hyperglycemia 01/2022 - 03/2012
7	Myocardial Infarction 01/2021 - 07/2010
7	Carcinoma (Carcinomatosis) 01/2019 - 04/2008
6	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 08/2006
6	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 03/2016
6	Squamous Cell Carcinoma of Head and Neck 12/2021 - 01/2017
5	Hypoxia (Hypoxemia) 06/2023 - 04/2007
5	Weight Gain 01/2022 - 01/2017
4	COVID-19 04/2024 - 01/2021
4	Diabetes Mellitus 01/2024 - 11/2006
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2023 - 09/2020
4	Hypersensitivity (Allergy) 01/2023 - 03/2012
4	Colonic Neoplasms (Colon Cancer) 10/2022 - 07/2006
4	Acute Coronary Syndrome 01/2022 - 08/2017
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 04/2018
4	Carcinogenesis 01/2021 - 10/2010
4	Liver Neoplasms (Liver Cancer) 01/2020 - 01/2013
4	Bacterial Infections (Bacterial Infection) 01/2019 - 06/2013
3	Parkinson Disease (Parkinson's Disease) 03/2024 - 03/2021
3	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 01/2016
3	Diarrhea 07/2023 - 06/2013
3	Virus Diseases (Viral Diseases) 04/2023 - 01/2021

Drug/Important Bio-Agent (IBA)

37	Proteins (Proteins, Gene)FDA Link 04/2024 - 04/2007
25	Glucose (Dextrose)FDA LinkGeneric 08/2023 - 11/2007
19	Biomarkers (Surrogate Marker)IBA 05/2024 - 05/2015
19	Insulin (Novolin)FDA Link 08/2023 - 05/2013
17	Therapeutic UsesIBA 04/2023 - 05/2006
14	LipidsIBA 09/2022 - 04/2005
13	CytokinesIBA 01/2024 - 01/2011
12	HydrogelsIBA 12/2023 - 03/2014
12	AntioxidantsIBA 10/2023 - 06/2013
11	CholesterolIBA 07/2022 - 11/2006
11	Messenger RNA (mRNA)IBA 12/2018 - 10/2011
10	Peptides (Polypeptides)IBA 01/2024 - 09/2015
8	Blood Glucose (Blood Sugar)IBA 01/2021 - 03/2012
8	Triglycerides (Triacylglycerol)IBA 01/2020 - 07/2013
8	Octreotide (Sandostatin)FDA LinkGeneric 07/2017 - 05/2006
7	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 10/2015
6	Small Interfering RNA (siRNA)IBA 10/2022 - 07/2010
6	CarbonIBA 01/2022 - 09/2017
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 12/2004
6	oxidized low density lipoproteinIBA 01/2021 - 05/2007
6	AMP-Activated Protein KinasesIBA 01/2017 - 01/2013
5	VaccinesIBA 12/2024 - 01/2021
5	Interleukin-6 (Interleukin 6)IBA 12/2023 - 01/2018
5	policosanolIBA 01/2023 - 05/2017
5	SaltsIBA 01/2023 - 01/2014
5	SodiumIBA 09/2022 - 01/2014
5	FlavonoidsIBA 01/2022 - 11/2020
5	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2017
5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2017 - 05/2006
4	InterferonsIBA 01/2024 - 07/2020
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024 - 10/2017
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 04/2007
4	EnzymesIBA 11/2023 - 09/2017
4	Phosphotransferases (Kinase)IBA 06/2023 - 02/2012
4	Interleukin-8 (Interleukin 8)IBA 06/2023 - 04/2020
4	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 12/2017
4	Hematoxylin (Haematoxylon)IBA 01/2022 - 12/2017
4	LDL CholesterolIBA 01/2022 - 01/2016
4	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2016
4	SmokeIBA 10/2021 - 09/2010
4	LuciferasesIBA 01/2021 - 04/2007
4	LigandsIBA 04/2020 - 09/2010
4	Transcription Factors (Transcription Factor)IBA 12/2019 - 04/2007
4	CollagenIBA 12/2019 - 12/2017
4	Arginine (L-Arginine)FDA Link 10/2018 - 02/2016
4	ApolipoproteinsIBA 01/2018 - 08/2007
4	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2018 - 12/2011
4	HDL CholesterolIBA 01/2016 - 11/2007
4	Immunoglobulin E (IgE)IBA 01/2014 - 01/2011
3	ChitosanIBA 05/2024 - 07/2015
3	Hormones (Hormone)IBA 03/2024 - 01/2020
3	Circular RNAIBA 01/2024 - 01/2020
3	InterleukinsIBA 01/2024 - 02/2013
3	Antineoplastic Agents (Antineoplastics)IBA 12/2023 - 01/2013
3	Transaminases (Aminotransferases)IBA 07/2023 - 05/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2023 - 09/2010
3	aumolertinibIBA 04/2023 - 01/2021

Therapy/Procedure

38	Therapeutics 12/2023 - 12/2004
15	Drug Therapy (Chemotherapy) 03/2024 - 12/2016
6	Lasers (Laser) 01/2023 - 09/2017
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2024 - 09/2022
3	Aftercare (After-Treatment) 01/2024 - 03/2014